R E McCabe

1.9k total citations
42 papers, 1.4k citations indexed

About

R E McCabe is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Parasitology. According to data from OpenAlex, R E McCabe has authored 42 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 13 papers in Public Health, Environmental and Occupational Health and 13 papers in Parasitology. Recurrent topics in R E McCabe's work include Trypanosoma species research and implications (8 papers), Research on Leishmaniasis Studies (7 papers) and Toxoplasma gondii Research Studies (7 papers). R E McCabe is often cited by papers focused on Trypanosoma species research and implications (8 papers), Research on Leishmaniasis Studies (7 papers) and Toxoplasma gondii Research Studies (7 papers). R E McCabe collaborates with scholars based in United States, Denmark and United Kingdom. R E McCabe's co-authors include J S Remington, Jack S. Remington, Benjamin J. Luft, Robert G. Brooks, Fausto G. Araujo, Brian Mullins, David N. Kunz, Dewei Zou, KAREN E. WARDEN and Thomas A. Zdeblick and has published in prestigious journals such as The Lancet, The Journal of Immunology and Clinical Infectious Diseases.

In The Last Decade

R E McCabe

41 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R E McCabe United States 19 679 507 276 265 255 42 1.4k
Chusana Suankratay Thailand 18 457 0.7× 74 0.1× 140 0.5× 253 1.0× 309 1.2× 77 1.2k
L. Sabbe Netherlands 18 273 0.4× 185 0.4× 87 0.3× 160 0.6× 310 1.2× 35 962
Ronald E. Keeney United States 21 1.4k 2.0× 148 0.3× 121 0.4× 121 0.5× 325 1.3× 36 1.8k
Shirley E. Maddison United States 22 203 0.3× 605 1.2× 220 0.8× 115 0.4× 374 1.5× 63 1.3k
Adnane Hammami Tunisia 21 321 0.5× 132 0.3× 133 0.5× 135 0.5× 175 0.7× 53 1.2k
G Huldt Sweden 19 293 0.4× 626 1.2× 110 0.4× 236 0.9× 292 1.1× 51 1.1k
Jennifer S. Daly United States 16 430 0.6× 348 0.7× 164 0.6× 187 0.7× 639 2.5× 36 1.2k
James Flexman Australia 21 803 1.2× 100 0.2× 264 1.0× 120 0.5× 577 2.3× 57 1.6k
A. M. M. Jokipii Finland 21 223 0.3× 559 1.1× 144 0.5× 191 0.7× 562 2.2× 50 1.3k
Robert E. Van Scoy United States 19 617 0.9× 54 0.1× 289 1.0× 119 0.4× 391 1.5× 48 1.5k

Countries citing papers authored by R E McCabe

Since Specialization
Citations

This map shows the geographic impact of R E McCabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R E McCabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R E McCabe more than expected).

Fields of papers citing papers by R E McCabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R E McCabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R E McCabe. The network helps show where R E McCabe may publish in the future.

Co-authorship network of co-authors of R E McCabe

This figure shows the co-authorship network connecting the top 25 collaborators of R E McCabe. A scholar is included among the top collaborators of R E McCabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R E McCabe. R E McCabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McCabe, R E, et al.. (2024). Flexible Coatings Facilitate pH-Targeted Drug Release via Self-Unfolding Foils: Applications for Oral Drug Delivery. Pharmaceutics. 16(1). 81–81. 3 indexed citations
2.
McCabe, R E, et al.. (2024). 4D printing of biodegradable intestinal drug delivery devices with shape-memory effect. International Journal of Pharmaceutics. 669. 125051–125051. 4 indexed citations
3.
McCabe, R E, et al.. (2023). Smart pills and drug delivery devices enabling next generation oral dosage forms. Journal of Controlled Release. 364. 227–245. 12 indexed citations
4.
Tedaldi, Ellen, Rania Baker, Anne C. Moorman, et al.. (2004). Hepatitis A and B Vaccination Practices for Ambulatory Patients Infected with HIV. Clinical Infectious Diseases. 38(10). 1478–1484. 100 indexed citations
5.
McCabe, R E, et al.. (1993). Comparison of the Efficacy and Safety of Ceftibuten and Cefaclor in the Treatment of Pneumonia and Bronchiectasis. Journal of Chemotherapy. 5(2). 124–132. 9 indexed citations
6.
Zdeblick, Thomas A., Dewei Zou, KAREN E. WARDEN, et al.. (1992). Cervical stability after foraminotomy. A biomechanical in vitro analysis.. Journal of Bone and Joint Surgery. 74(1). 22–27. 218 indexed citations
7.
Edelstein, Howard & R E McCabe. (1991). Candida albicans septic arthritis and osteomyelitis of the sternoclavicular joint in a patient with human immunodeficiency virus infection.. PubMed. 18(1). 110–1. 34 indexed citations
8.
McCabe, R E, et al.. (1991). Endogenous Interferon- , Macrophage Activation, and Murine Host Defense against Acute Infection with Trypanosoma cruzi. The Journal of Infectious Diseases. 163(4). 912–915. 43 indexed citations
9.
McCabe, R E. (1990). Current diagnosis and management of toxoplasmosis in cancer patients.. PubMed. 4(10). 81–90; discussion 93. 6 indexed citations
10.
McCabe, R E, et al.. (1989). Comparison of once-daily cephalosporin regimens for community-acquired lower respiratory tract infections in patients with chronic lung disease.. PubMed. 11(3). 304–14. 8 indexed citations
11.
Edelstein, Howard, et al.. (1989). Perinephric Abscess in Renal Transplant Recipients: Report of Seven Cases and Review. Clinical Infectious Diseases. 11(4). 569–577. 16 indexed citations
12.
Edelstein, Howard, et al.. (1988). Carumonam versus ceftazidime for urinary tract infections. Antimicrobial Agents and Chemotherapy. 32(7). 1031–1033. 1 indexed citations
13.
Brooks, Robert G., R E McCabe, & J S Remington. (1987). Role of Serology in the Diagnosis of Toxoplasmic Lymphadenopathy. Clinical Infectious Diseases. 9(5). 1055–1062. 56 indexed citations
14.
McCabe, R E, et al.. (1987). Role of Serology in the Diagnosis of Toxoplasmic Lymphadenopathy. Clinical Infectious Diseases. 9(4). 775–782. 7 indexed citations
15.
McCabe, R E, J R Catterall, & Jack S. Remington. (1987). Unique Differences in Infectivity and Seroreactivity of Toxoplasma Harvested from Mice Infected for Different Lengths of Time. Journal of Parasitology. 73(6). 1152–1152. 3 indexed citations
16.
Reed, Elaine F., Melinda Y. Hardy, Jeffrey M. Brensilver, et al.. (1987). Anti-idiotypic antibodies to HLA and their influence on patient sensitization.. PubMed. 19(1 Pt 1). 762–3. 9 indexed citations
17.
McCabe, R E, Robert G. Brooks, R F Dorfman, & Jack S. Remington. (1987). Clinical Spectrum in 107 Cases of Toxoplasmic Lymphadenopathy. Clinical Infectious Diseases. 9(4). 754–774. 104 indexed citations
18.
McCabe, R E, Jack S. Remington, & Fausto G. Araujo. (1984). Mechanisms of invasion and replication of the intracellular stage in Trypanosoma cruzi. Infection and Immunity. 46(2). 372–376. 21 indexed citations
19.
McCabe, R E, Benjamin J. Luft, & J S Remington. (1984). Effect of Murine Interferon Gamma on Murine Toxoplasmosis. The Journal of Infectious Diseases. 150(6). 961–962. 146 indexed citations
20.
McCabe, R E & Jack S. Remington. (1983). The diagnosis and treatment of toxoplasmosis. European Journal of Clinical Microbiology & Infectious Diseases. 2(2). 95–104. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026